New patient safety goals for 2005 by the Joint Commission on Accreditation of
Healthcare Organizations include preventing patient falls and avoiding potentially
fatal mix-ups with similarly named drugs.

Remaining unchanged from 2004 are the two key infection control patient safety
goals:

1. Comply with current Centers for Disease Control and Prevention hand
hygiene guidelines.

2. Manage as sentinel events all identified cases of unanticipated death
or major permanent loss of function associated with a health care-associated infection.

Goals include patient falls reduction

Effective Jan. 1, 2005, the patient safety goals also include a new emphasis
on reducing patient falls.

Infection control professionals have focused on this area before as an important
noninfectious adverse outcome.

The Joint Commission’s new patient safety goal calls for hospitals to "assess
and periodically reassess each patient’s risk for falling, including the potential
risk associated with the patient’s medication regimen, and take action to address
any identified risks."

Much emphasis is placed on medication in general, with the Joint Commission adding
a goal for 2005 that calls for hospitals to "accurately and completely reconcile
medications across the continuum of care."

That goal states that "during 2005, for full implementation by January 2006,
develop a process for obtaining and documenting a complete list of the patient’s
current medications upon the patient’s admission to the organization and with the
involvement of the patient.

This process includes a comparison of the medications the organization provides
to those on the list.

A complete list of the patient’s medications is communicated to the next provider
of service when it refers or transfers a patient to another setting, service, practitioner
or level of care within or outside the organization."

In addition, the Joint Commission calls for hospitals to "identify and, at a
minimum, annually review a list of look-alike/sound-alike drugs used in the organization,
and take action to prevent errors involving the interchange of these drugs."

The Joint Commission notes that many drug names can look or sound like other
drug names, which may lead to potentially harmful medication errors.

Communication issues exacerbate problem

Increasingly, pharmaceutical manufacturers and regulatory authorities are taking
measures to determine if there are unacceptable similarities between proposed names
and products on the market. But factors such as poor handwriting or poorly communicated
oral prescriptions can exacerbate the problem, the organization states.

To prevent potentially deadly interactions or inappropriate care, the Joint Commission
lists the following tips:

• Maintain awareness of look-alike and sound-alike drug names as published by
various safety agencies.

• Clearly specify the dosage form, drug strength, and complete directions on
prescriptions. These variables may help staff differentiate products.

• With name pairs known to be problematic, reduce the potential for confusion
by writing prescriptions using both the brand and generic name.

• Include the purpose of medication on prescriptions. In most cases, drugs that
sound or look similar are used for different purposes.

• Alert patients to the potential for mix-ups, especially with known problematic
drug names. Advise ambulatory care patients to insist on pharmacy counseling when
picking up prescriptions, and to verify that the medication and directions match
what the prescriber has told them.

• Encourage inpatients to question nurses about medications that are unfamiliar
or look or sound different than expected.

• Give verbal or telephone orders only when truly necessary, and never for chemotherapeutics.
Include the drug’s intended purpose to ensure clarity. Encourage staff to read back
all orders, spell the product name, and state its indication.

• Consider the possibility of name confusion when adding a new product to the
formulary. Review information previously published by safety agencies.

• Computerize prescribing. Use preprinted orders or prescriptions as appropriate.
If possible, print out current medications daily from the pharmacy computer system
and have physicians review for accuracy.

• When possible, list brand and generic names on medication administration records
and automated dispensing cabinet computer screens. Such redundancy could help someone
identify an error.

• Store products with look- or sound-alike names in different locations in pharmacies,
patient care units, and in other settings, including patient homes. When applicable,
use a shelf sticker to help locate the product that has been moved.

• Continue to employ independent double-checks in the dispensing process (one
person interprets and enters the prescription into the computer and another reviews
the printed label against the original prescription and the product prior to dispensing).

• Encourage
reporting of errors and potentially hazardous conditions with look-alike and
sound-alike product names and use the information to establish priorities for
error reduction.

Post a comment to this article

Name*

E-mail(will not be displayed)*

Subject

Comment*

Report Abusive Comment

Thank you for helping us to improve our forums. Is this comment offensive? Please tell us why.

Restricted Content

You must have JavaScript enabled to enjoy a limited number of articles over the next 360 days.